CAS No. |
82989-21-7 |
|---|---|
中文名称 |
9,12,21,24-四(4-氨基丁基)-15,18-二仲丁基-33-(2-羧乙基)-6-(4-羟基苄基)-36-(羟甲基)-3,27,30-三异丁基-1,4,7,10,13,16,19,22,25,28,31,34-十二氧代-1-(吡咯烷-2-基)-2,5,8,11,14,17,20,23,26,29,32,35-十二氮杂庚三十七烷-37-酸 |
英文名称 |
9,12,21,24-tetrakis(4-aminobutyl)-15,18-di-sec-butyl-33-(2-carboxyethyl)-6-(4-hydroxybenzyl)-36-(hydroxymethyl)-3,27,30-triisobutyl-1,4,7,10,13,16,19,22,25,28,31,34-dodecaoxo-1-(pyrrolidin-2-yl)-2,5,8,11,14,17,20,23,26,29,32,35-dodecaazaheptatriacontan-37-oic acid |
别名 |
H-PRO-LEU-TYR-LYS-LYS-ILE-ILE-LYS-LYS-LEU-LEU-GLU-SER-OH;platelet factor 4 fragment 58-70 human;PF4 (58-70) (HUMAN);PLATELET FACTOR 4 (58-70) (HUMAN);PLATELET FACTOR-4 (HUMAN, 58-70);PRO-LEU-TYR-LYS-LYS-ILE-ILE-LYS-LYS-LEU-LEU-GLU-SER;L-Prolyl-L-leucyl-L-tyrosyl-L-lysyl-L-lysyl-L-isoleucyl-L-isoleucyl-L-lysyl-L-lysyl-L-leucyl-L-leucyl-L-α-glutamyl-L-serine;PLATELET FACTOR 4 (58-70) (HUMAN) USP/EP/BP |
标准英文名 |
9,12,21,24-tetrakis(4-aminobutyl)-15,18-di-sec-butyl-33-(2-carboxyethyl)-6-(4-hydroxybenzyl)-36-(hydroxymethyl)-3,27,30-triisobutyl-1,4,7,10,13,16,19,22,25,28,31,34-dodecaoxo-1-(pyrrolidin-2-yl)-2,5,8,11,14,17,20,23,26,29,32,35-dodecaazaheptatriacontan-37-oic acid |
MDL No. |
MFCD00237228 |
分子式 |
C76H133N17O18 |
分子量 |
1573.00 |
精确分子量 |
1572.00 |
SMILES |
CCC(C)C(NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CC1=CC=C(O)C=C1)NC(=O)C(CC(C)C)NC(=O)C1CCCN1)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)O)C(C)CC |
标准SMILES |
CC(CC)C(NC(=O)C(CCCCN)NC(=O)C(CCCCN)NC(=O)C(CC1C=CC(O)=CC=1)NC(=O)C(CC(C)C)NC(=O)C1CCCN1)C(=O)NC(C(C)CC)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CO)C(O)=O |
用途 |
Contains the major heparin-binding domain of platelet factor 4 (PF4); insufficient for full anti-angiogenic activity. |
InChIKey |
SACBPCXTLNEHGC-UHFFFAOYSA-N |
|
|
评论 |
|---|